Piletič Klara, Kunej Tanja
Department of Animal Science, Biotechnical Faculty, University of Ljubljana, Groblje 3, 1230, Domzale, Slovenia.
Arch Toxicol. 2016 Oct;90(10):2405-19. doi: 10.1007/s00204-016-1815-7. Epub 2016 Aug 24.
MicroRNAs (miRNAs) are short non-coding RNAs that act as important regulators of gene expression as part of the epigenetic machinery. In addition to posttranscriptional gene silencing by miRNAs, the epigenetic mechanisms also include DNA methylation, histone modifications and their crosstalk. Epigenetic modifications were reported to play an important role in many disease onsets and progressions and can be used to explain several features of complex diseases, such as late onset and fluctuation of symptoms. However, miRNAs not only function as a part of epigenetic machinery, but are also epigenetically modified by DNA methylation and histone modification like any other protein-coding gene. There is a strong connection between epigenome and miRNome, and any dysregulation of this complex system can result in various physiological and pathological conditions. In addition, miRNAs play an important role in toxicogenomics and may explain the relationship between toxicant exposure and tumorigenesis. The present review provides information on 63 miRNA genes shown to be epigenetically regulated in association with 21 diseases, including 11 cancer types: cardiac fibrosis, cardiovascular disease, preeclampsia, Hirschsprung's disease, rheumatoid arthritis, systemic sclerosis, systemic lupus erythematosus, temporal lobe epilepsy, autism, pulmonary fibrosis, melanoma, acute myeloid leukemia, chronic lymphocytic leukemia, colorectal, gastric, cervical, ovarian, prostate, lung, breast, and bladder cancer. The review revealed that hsa-miR-34a, hsa-miR-34b, and hsa-miR-34c are the most frequently reported epigenetically dysregulated miRNAs. There is a need to further study molecular mechanisms of various diseases to better understand the crosstalk between epigenetics and gene expression and to develop new therapeutic options and biomarkers.
微小RNA(miRNA)是短链非编码RNA,作为表观遗传机制的一部分,是基因表达的重要调节因子。除了miRNA介导的转录后基因沉默外,表观遗传机制还包括DNA甲基化、组蛋白修饰及其相互作用。据报道,表观遗传修饰在许多疾病的发生和发展中起重要作用,可用于解释复杂疾病的一些特征,如发病较晚和症状波动。然而,miRNA不仅作为表观遗传机制的一部分发挥作用,而且像任何其他蛋白质编码基因一样,也会受到DNA甲基化和组蛋白修饰的表观遗传修饰。表观基因组和miRNA组之间存在着紧密的联系,这个复杂系统的任何失调都可能导致各种生理和病理状况。此外,miRNA在毒理基因组学中发挥重要作用,可能解释毒物暴露与肿瘤发生之间的关系。本综述提供了63个miRNA基因的信息,这些基因显示与21种疾病相关,包括11种癌症类型:心脏纤维化、心血管疾病、先兆子痫、先天性巨结肠、类风湿性关节炎、系统性硬化症、系统性红斑狼疮、颞叶癫痫、自闭症、肺纤维化、黑色素瘤、急性髓系白血病、慢性淋巴细胞白血病、结直肠癌、胃癌、宫颈癌、卵巢癌、前列腺癌、肺癌、乳腺癌和膀胱癌。该综述表明,hsa-miR-34a、hsa-miR-34b和hsa-miR-34c是最常报道的表观遗传失调的miRNA。有必要进一步研究各种疾病的分子机制,以更好地理解表观遗传学与基因表达之间的相互作用,并开发新的治疗方法和生物标志物。